Associated Papers
A novel oncostatin M/interleukin-31 receptor mutation in familial primary localized cutaneous amyloidosis.
Adams R et al.
Clinical and Experimental Dermatology, 2020
Clinical and genetic features of Chinese patients with lichen and macular primary localized cutaneous amyloidosis.
Lu P et al.
Clinical and Experimental Dermatology, 2019
Primary Localized Cutaneous Amyloidosis Affecting Female Individuals of a Pakistani Pedigree.
Bhoyrul B et al.
The American Journal of Dermatopathology, 2019
[Identification of pathogenic mutations in two Chinese families affected with primary localized cutaneous amyloidosis].
Mao B et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2018
A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
Saeedi M et al.
Biomed Research International, 2014
Familial primary localized cutaneous amyloidosis with an oncostatin M receptor-β mutation, Pro694Leu.
Schreml S et al.
Clinical and Experimental Dermatology, 2013
The molecular skin pathology of familial primary localized cutaneous amyloidosis.
Tanaka A et al.
Experimental Dermatology, 2010
Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis.
Lin MW et al.
European Journal of Human Genetics : Ejhg, 2010
New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis.
Tanaka A et al.
The British Journal of Dermatology, 2009
Select a paper to view details